世界のトゥレット症候群治療薬市場

QYResearchが発行した調査報告書(QYR802A5508)
◆英語タイトル:Global Tourette Syndrome Drug Sales Market Report 2017
◆商品コード:QYR802A5508
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年1月
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポート(2018年版)では、トゥレット症候群治療薬のグローバル市場について調査・分析し、トゥレット症候群治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(米国、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、トゥレット症候群治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・トゥレット症候群治療薬市場概要
・トゥレット症候群治療薬のメーカー別販売量・メーカー別シェア
・トゥレット症候群治療薬の世界市場:種類別販売量・市場シェア
・トゥレット症候群治療薬の世界市場:用途別販売量・市場シェア
・トゥレット症候群治療薬の世界市場:地域別販売量・市場シェア
・トゥレット症候群治療薬の米国市場規模
・トゥレット症候群治療薬の中国市場規模
・トゥレット症候群治療薬のヨーロッパ市場規模
・トゥレット症候群治療薬の日本市場規模
・トゥレット症候群治療薬の東南アジア市場規模
・トゥレット症候群治療薬のインド市場規模
・トゥレット症候群治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・トゥレット症候群治療薬のコスト分析・価格動向
・トゥレット症候群治療薬の産業チェーン(サプライチェーン分析)
・トゥレット症候群治療薬のマーケティング戦略・販売チャネル、流通業者
・トゥレット症候群治療薬市場への影響要因分析
・トゥレット症候群治療薬の世界市場予測
・トゥレット症候群治療薬のアメリカ市場予測
・トゥレット症候群治療薬の中国市場予測
・トゥレット症候群治療薬のヨーロッパ市場予測
・トゥレット症候群治療薬の日本市場予測
・トゥレット症候群治療薬の東南アジア市場予測
・トゥレット症候群治療薬のインド市場予測
・トゥレット症候群治療薬の種類別世界市場予測
・トゥレット症候群治療薬の用途別世界市場予測
...
【レポートの概要】

In this report, the global Tourette Syndrome Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Tourette Syndrome Drug for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Tourette Syndrome Drug market competition by top manufacturers/players, with Tourette Syndrome Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Abide Therapeutics Inc
Catalyst Pharmaceuticals Inc
Neurocrine Biosciences Inc
Psyadon Pharmaceuticals Inc
Reviva Pharmaceuticals Inc
Synchroneuron Inc
Teva Pharmaceutical Industries Ltd
Therapix Biosciences Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AZD-5213
CPP-115
Dutetrabenazine ER
Ecopipam Hydrochloride
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Research Center
Hospital
Clinic
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Tourette Syndrome Drug Sales Market Report 2017
1 Tourette Syndrome Drug Market Overview
1.1 Product Overview and Scope of Tourette Syndrome Drug
1.2 Classification of Tourette Syndrome Drug by Product Category
1.2.1 Global Tourette Syndrome Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Tourette Syndrome Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 AZD-5213
1.2.4 CPP-115
1.2.5 Dutetrabenazine ER
1.2.6 Ecopipam Hydrochloride
1.2.7 Others
1.3 Global Tourette Syndrome Drug Market by Application/End Users
1.3.1 Global Tourette Syndrome Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Global Tourette Syndrome Drug Market by Region
1.4.1 Global Tourette Syndrome Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Tourette Syndrome Drug Status and Prospect (2012-2022)
1.4.3 China Tourette Syndrome Drug Status and Prospect (2012-2022)
1.4.4 Europe Tourette Syndrome Drug Status and Prospect (2012-2022)
1.4.5 Japan Tourette Syndrome Drug Status and Prospect (2012-2022)
1.4.6 Southeast Asia Tourette Syndrome Drug Status and Prospect (2012-2022)
1.4.7 India Tourette Syndrome Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Tourette Syndrome Drug (2012-2022)
1.5.1 Global Tourette Syndrome Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Tourette Syndrome Drug Revenue and Growth Rate (2012-2022)

2 Global Tourette Syndrome Drug Competition by Players/Suppliers, Type and Application
2.1 Global Tourette Syndrome Drug Market Competition by Players/Suppliers
2.1.1 Global Tourette Syndrome Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Tourette Syndrome Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Tourette Syndrome Drug (Volume and Value) by Type
2.2.1 Global Tourette Syndrome Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Tourette Syndrome Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Tourette Syndrome Drug (Volume and Value) by Region
2.3.1 Global Tourette Syndrome Drug Sales and Market Share by Region (2012-2017)
2.3.2 Global Tourette Syndrome Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Tourette Syndrome Drug (Volume) by Application

3 United States Tourette Syndrome Drug (Volume, Value and Sales Price)
3.1 United States Tourette Syndrome Drug Sales and Value (2012-2017)
3.1.1 United States Tourette Syndrome Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Tourette Syndrome Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Tourette Syndrome Drug Sales Price Trend (2012-2017)
3.2 United States Tourette Syndrome Drug Sales Volume and Market Share by Players
3.3 United States Tourette Syndrome Drug Sales Volume and Market Share by Type
3.4 United States Tourette Syndrome Drug Sales Volume and Market Share by Application

4 China Tourette Syndrome Drug (Volume, Value and Sales Price)
4.1 China Tourette Syndrome Drug Sales and Value (2012-2017)
4.1.1 China Tourette Syndrome Drug Sales and Growth Rate (2012-2017)
4.1.2 China Tourette Syndrome Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Tourette Syndrome Drug Sales Price Trend (2012-2017)
4.2 China Tourette Syndrome Drug Sales Volume and Market Share by Players
4.3 China Tourette Syndrome Drug Sales Volume and Market Share by Type
4.4 China Tourette Syndrome Drug Sales Volume and Market Share by Application

5 Europe Tourette Syndrome Drug (Volume, Value and Sales Price)
5.1 Europe Tourette Syndrome Drug Sales and Value (2012-2017)
5.1.1 Europe Tourette Syndrome Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Tourette Syndrome Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Tourette Syndrome Drug Sales Price Trend (2012-2017)
5.2 Europe Tourette Syndrome Drug Sales Volume and Market Share by Players
5.3 Europe Tourette Syndrome Drug Sales Volume and Market Share by Type
5.4 Europe Tourette Syndrome Drug Sales Volume and Market Share by Application

6 Japan Tourette Syndrome Drug (Volume, Value and Sales Price)
6.1 Japan Tourette Syndrome Drug Sales and Value (2012-2017)
6.1.1 Japan Tourette Syndrome Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Tourette Syndrome Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Tourette Syndrome Drug Sales Price Trend (2012-2017)
6.2 Japan Tourette Syndrome Drug Sales Volume and Market Share by Players
6.3 Japan Tourette Syndrome Drug Sales Volume and Market Share by Type
6.4 Japan Tourette Syndrome Drug Sales Volume and Market Share by Application

7 Southeast Asia Tourette Syndrome Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Tourette Syndrome Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Tourette Syndrome Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Tourette Syndrome Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Tourette Syndrome Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Tourette Syndrome Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Tourette Syndrome Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Tourette Syndrome Drug Sales Volume and Market Share by Application

8 India Tourette Syndrome Drug (Volume, Value and Sales Price)
8.1 India Tourette Syndrome Drug Sales and Value (2012-2017)
8.1.1 India Tourette Syndrome Drug Sales and Growth Rate (2012-2017)
8.1.2 India Tourette Syndrome Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Tourette Syndrome Drug Sales Price Trend (2012-2017)
8.2 India Tourette Syndrome Drug Sales Volume and Market Share by Players
8.3 India Tourette Syndrome Drug Sales Volume and Market Share by Type
8.4 India Tourette Syndrome Drug Sales Volume and Market Share by Application

9 Global Tourette Syndrome Drug Players/Suppliers Profiles and Sales Data
9.1 Abide Therapeutics Inc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Tourette Syndrome Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Catalyst Pharmaceuticals Inc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Tourette Syndrome Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Neurocrine Biosciences Inc
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Tourette Syndrome Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Psyadon Pharmaceuticals Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Tourette Syndrome Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Reviva Pharmaceuticals Inc
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Tourette Syndrome Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Synchroneuron Inc
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Tourette Syndrome Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Teva Pharmaceutical Industries Ltd
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Tourette Syndrome Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Therapix Biosciences Ltd
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Tourette Syndrome Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview

10 Tourette Syndrome Drug Maufacturing Cost Analysis
10.1 Tourette Syndrome Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Tourette Syndrome Drug
10.3 Manufacturing Process Analysis of Tourette Syndrome Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Tourette Syndrome Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Tourette Syndrome Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Tourette Syndrome Drug Market Forecast (2017-2022)
14.1 Global Tourette Syndrome Drug Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Tourette Syndrome Drug Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Tourette Syndrome Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Tourette Syndrome Drug Price and Trend Forecast (2017-2022)
14.2 Global Tourette Syndrome Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Tourette Syndrome Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Tourette Syndrome Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Tourette Syndrome Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Tourette Syndrome Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Tourette Syndrome Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Tourette Syndrome Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Tourette Syndrome Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Tourette Syndrome Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Tourette Syndrome Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Tourette Syndrome Drug Sales Forecast by Type (2017-2022)
14.3.2 Global Tourette Syndrome Drug Revenue Forecast by Type (2017-2022)
14.3.3 Global Tourette Syndrome Drug Price Forecast by Type (2017-2022)
14.4 Global Tourette Syndrome Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Tourette Syndrome Drug
Figure Global Tourette Syndrome Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Tourette Syndrome Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure AZD-5213 Product Picture
Figure CPP-115 Product Picture
Figure Dutetrabenazine ER Product Picture
Figure Ecopipam Hydrochloride Product Picture
Figure Others Product Picture
Figure Global Tourette Syndrome Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Tourette Syndrome Drug by Application in 2016
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Tourette Syndrome Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Tourette Syndrome Drug Sales Volume (K Pcs) (2012-2017)
Table Global Tourette Syndrome Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Tourette Syndrome Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Tourette Syndrome Drug Sales Share by Players/Suppliers
Figure 2017 Tourette Syndrome Drug Sales Share by Players/Suppliers
Figure Global Tourette Syndrome Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Tourette Syndrome Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Tourette Syndrome Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Tourette Syndrome Drug Revenue Share by Players
Table 2017 Global Tourette Syndrome Drug Revenue Share by Players
Table Global Tourette Syndrome Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Tourette Syndrome Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Tourette Syndrome Drug by Type (2012-2017)
Figure Global Tourette Syndrome Drug Sales Growth Rate by Type (2012-2017)
Table Global Tourette Syndrome Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Tourette Syndrome Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Tourette Syndrome Drug by Type (2012-2017)
Figure Global Tourette Syndrome Drug Revenue Growth Rate by Type (2012-2017)
Table Global Tourette Syndrome Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Tourette Syndrome Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Tourette Syndrome Drug by Region (2012-2017)
Figure Global Tourette Syndrome Drug Sales Growth Rate by Region in 2016
Table Global Tourette Syndrome Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Tourette Syndrome Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Tourette Syndrome Drug by Region (2012-2017)
Figure Global Tourette Syndrome Drug Revenue Growth Rate by Region in 2016
Table Global Tourette Syndrome Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Tourette Syndrome Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Tourette Syndrome Drug by Region (2012-2017)
Figure Global Tourette Syndrome Drug Revenue Market Share by Region in 2016
Table Global Tourette Syndrome Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Tourette Syndrome Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Tourette Syndrome Drug by Application (2012-2017)
Figure Global Tourette Syndrome Drug Sales Market Share by Application (2012-2017)
Figure United States Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Tourette Syndrome Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Tourette Syndrome Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Tourette Syndrome Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Tourette Syndrome Drug Sales Volume Market Share by Players in 2016
Table United States Tourette Syndrome Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Tourette Syndrome Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Tourette Syndrome Drug Sales Volume Market Share by Type in 2016
Table United States Tourette Syndrome Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Tourette Syndrome Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Tourette Syndrome Drug Sales Volume Market Share by Application in 2016
Figure China Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Tourette Syndrome Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Tourette Syndrome Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Tourette Syndrome Drug Sales Volume Market Share by Players (2012-2017)
Figure China Tourette Syndrome Drug Sales Volume Market Share by Players in 2016
Table China Tourette Syndrome Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Tourette Syndrome Drug Sales Volume Market Share by Type (2012-2017)
Figure China Tourette Syndrome Drug Sales Volume Market Share by Type in 2016
Table China Tourette Syndrome Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Tourette Syndrome Drug Sales Volume Market Share by Application (2012-2017)
Figure China Tourette Syndrome Drug Sales Volume Market Share by Application in 2016
Figure Europe Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Tourette Syndrome Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Tourette Syndrome Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Tourette Syndrome Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Tourette Syndrome Drug Sales Volume Market Share by Players in 2016
Table Europe Tourette Syndrome Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Tourette Syndrome Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Tourette Syndrome Drug Sales Volume Market Share by Type in 2016
Table Europe Tourette Syndrome Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Tourette Syndrome Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Tourette Syndrome Drug Sales Volume Market Share by Application in 2016
Figure Japan Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Tourette Syndrome Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Tourette Syndrome Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Tourette Syndrome Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Tourette Syndrome Drug Sales Volume Market Share by Players in 2016
Table Japan Tourette Syndrome Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Tourette Syndrome Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Tourette Syndrome Drug Sales Volume Market Share by Type in 2016
Table Japan Tourette Syndrome Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Tourette Syndrome Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Tourette Syndrome Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Tourette Syndrome Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Tourette Syndrome Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Tourette Syndrome Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Tourette Syndrome Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Tourette Syndrome Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Tourette Syndrome Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Tourette Syndrome Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Tourette Syndrome Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Tourette Syndrome Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Tourette Syndrome Drug Sales Volume Market Share by Application in 2016
Figure India Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Tourette Syndrome Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Tourette Syndrome Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Tourette Syndrome Drug Sales Volume Market Share by Players (2012-2017)
Figure India Tourette Syndrome Drug Sales Volume Market Share by Players in 2016
Table India Tourette Syndrome Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Tourette Syndrome Drug Sales Volume Market Share by Type (2012-2017)
Figure India Tourette Syndrome Drug Sales Volume Market Share by Type in 2016
Table India Tourette Syndrome Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Tourette Syndrome Drug Sales Volume Market Share by Application (2012-2017)
Figure India Tourette Syndrome Drug Sales Volume Market Share by Application in 2016
Table Abide Therapeutics Inc Basic Information List
Table Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Abide Therapeutics Inc Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Catalyst Pharmaceuticals Inc Basic Information List
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Neurocrine Biosciences Inc Basic Information List
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Psyadon Pharmaceuticals Inc Basic Information List
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Reviva Pharmaceuticals Inc Basic Information List
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Synchroneuron Inc Basic Information List
Table Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Synchroneuron Inc Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Synchroneuron Inc Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Synchroneuron Inc Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Therapix Biosciences Ltd Basic Information List
Table Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales Growth Rate (2012-2017)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales Global Market Share (2012-2017
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tourette Syndrome Drug
Figure Manufacturing Process Analysis of Tourette Syndrome Drug
Figure Tourette Syndrome Drug Industrial Chain Analysis
Table Raw Materials Sources of Tourette Syndrome Drug Major Players in 2016
Table Major Buyers of Tourette Syndrome Drug
Table Distributors/Traders List
Figure Global Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Tourette Syndrome Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Tourette Syndrome Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Tourette Syndrome Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Tourette Syndrome Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Tourette Syndrome Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Tourette Syndrome Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Tourette Syndrome Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Tourette Syndrome Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Tourette Syndrome Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Tourette Syndrome Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のトゥレット症候群治療薬市場(Global Tourette Syndrome Drug Sales Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆